|Articles|August 14, 2008 (Updated: November 14, 2020)
Drug Designed to Fight MS Could Target Viral Infections
Advertisement
Reuters is reporting today that a new drug, FTY720, also called fingolimod, that Novartis AG is testing in individuals with multiple sclerosis could also tackle some viral infections, including perhaps including meningitis and perhaps even the AIDS virus. For the complete article,
Source: Reuters
Newsletter
Stay prepared and protected with Infection Control Today's newsletter, delivering essential updates, best practices, and expert insights for infection preventionists.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Infection Control Today
1
Beyond Viral Suppression: Next-Generation HIV Therapeutics Target Reservoirs, Broadly Neutralizing Antibodies, and Gene Editing
2
Ultrasonic Cleaning Is Not a Machine; It Is a Quality System: Preventing Hidden Bioburden in Surgical Instruments
3
2025 APIC President Carol McLay, DrPH, Reflects on Advocacy, Global Collaboration, and the Future of Infection Prevention
4
Hospital-Onset Bacteremia in Burn Patients May Be a Poor Quality Metric, Study Finds
5